Thrombelastography for Coagulopathy in Chinese Snakebites

Inclusion Criteria: * Age: Participants aged 18-65 years. * Diagnosis: Confirmed diagnosis of venom-induced consumptive coagulopathy caused by snake envenomation. * Time of Enrollment: Participants who present with symptoms of venom poisoning within 6 hours of snake bite. * Consent: Capable of providing written informed consent, or consent provided by a legal guardian if the participant is incapacitated. * Vital Signs: Stable vital signs at the time of enrollment, with systolic blood pressure \> 90 mmHg. * Laboratory Results: Coagulation parameters (e.g., PT, aPTT, fibrinogen, platelet count) indicating acute coagulopathy. Exclusion Criteria: * Pregnancy or Breastfeeding: Women who are pregnant or breastfeeding. * Severe Comorbidities: Participants with severe liver disease (e.g., cirrhosis), renal failure, or significant cardiovascular conditions (e.g., heart failure). * Previous Snake Envenomation: Participants who have received antivenom for a snake bite in the past 30 days. * Severe Allergies: Known allergy to snake venom antivenom or any of its components. * Concurrent Participation in Other Clinical Trials: Participants who are currently enrolled in another clinical trial. * Severe Coagulopathy or Bleeding Disorders: Participants with known pre-existing coagulation disorders such as hemophilia, or those with abnormal baseline blood tests suggesting coagulopathy unrelated to the snake bite. * Immunocompromised Patients: Individuals with HIV/AIDS, or who are on immunos…